BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Saab S, Brown RS Jr. Management of Thrombocytopenia in Patients with Chronic Liver Disease. Dig Dis Sci 2019;64:2757-68. [PMID: 31011942 DOI: 10.1007/s10620-019-05615-5] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Lin Y, Wei H. Platelet Abnormalities after Splenectomy for Hypersplenism in Decompensated Cirrhosis: A Case Report. AJST 2023;5:75-77. [DOI: 10.54097/ajst.v5i1.5391] [Reference Citation Analysis]
2 Ding JN, Feng TT, Sun W, Cai XY, Zhang Y, Zhao WF. Recombinant human thrombopoietin treatment in patients with chronic liver disease-related thrombocytopenia undergoing invasive procedures: A retrospective study. World J Gastrointest Surg 2022; 14(11): 1260-1271 [DOI: 10.4240/wjgs.v14.i11.1260] [Reference Citation Analysis]
3 Huang A, Chen J, Wu J, Gao Z, Shi Y, Fu X, Zhang X, Liu W, Gao Q, Sun H, Shi G, Fan J, Ding Z, Zhou J. Effectiveness and Safety of Avatrombopag in Liver Cancer Patients with Severe Thrombocytopenia: Real-World Data and Challenges. Journal of Oncology 2022;2022:1-11. [DOI: 10.1155/2022/9138195] [Reference Citation Analysis]
4 Satoh T, Takiguchi H, Uojima H, Kubo M, Tanaka C, Yokoyama F, Wada N, Miyazaki K, Hidaka H, Kusano C, Kuwana M, Horie R. B cell-activating factor is involved in thrombocytopenia in patients with liver cirrhosis. Ann Hematol 2022. [PMID: 36098792 DOI: 10.1007/s00277-022-04973-x] [Reference Citation Analysis]
5 Gallo P, Terracciani F, Di Pasquale G, Esposito M, Picardi A, Vespasiani-Gentilucci U. Thrombocytopenia in chronic liver disease: Physiopathology and new therapeutic strategies before invasive procedures. World J Gastroenterol 2022; 28(30): 4061-4074 [DOI: 10.3748/wjg.v28.i30.4061] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Velarde-Ruiz Velasco JA, García-Jiménez ES, Aldana-Ledesma JM, Tapia-Calderón DK, Tornel-Avelar AI, Lazcano-Becerra M, Chávez-Ramírez RM, Cano-Contreras AD, Remes-Troche JM, Colunga-Lozano LE, Montaño-Loza A. Evaluation and management of emergencies in the patient with cirrhosis. Rev Gastroenterol Mex (Engl Ed) 2022:S2255-534X(22)00029-9. [PMID: 35570104 DOI: 10.1016/j.rgmxen.2022.05.001] [Reference Citation Analysis]
7 Römer P, Heimes D, Pabst A, Becker P, Thiem DGE, Kämmerer PW. Bleeding disorders in implant dentistry: a narrative review and a treatment guide. Int J Implant Dent 2022;8. [DOI: 10.1186/s40729-022-00418-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Velarde-ruiz Velasco J, García-jiménez E, Aldana-ledesma J, Tapia-calderón D, Tornel-avelar A, Lazcano-becerra M, Chávez-ramírez R, Cano-contreras A, Remes-troche J, Colunga-lozano L, Montaño-loza A. Evaluación y manejo de emergencias en el paciente con cirrosis. Revista de Gastroenterología de México 2022;87:198-215. [DOI: 10.1016/j.rgmx.2021.11.002] [Reference Citation Analysis]
9 Xu X, Li C, Chen J, Liu X, Su H, Tong J, Hu J. Relationship Between Platelet to White Blood Cell Ratio and 30-Day Prognosis of Patients with Acute-on-Chronic Liver Failure. Hepat Mon 2021;21. [DOI: 10.5812/hepatmon.118640] [Reference Citation Analysis]
10 Yoshiji H, Ueno Y, Kurosaki M, Torimura T, Hatano E, Yatsuhashi H, Yamakado K. Treatment algorithm for thrombocytopenia in patients with chronic liver disease undergoing planned invasive procedures. Hepatol Res 2021;51:1181-95. [PMID: 34555262 DOI: 10.1111/hepr.13715] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Aguiar AJFC, de Queiroz JLC, Santos PPA, Camillo CS, Serquiz AC, Costa IS, Oliveira GS, Gomes AFT, Matias LLR, Costa ROA, Passos TS, Morais AHA. Beneficial Effects of Tamarind Trypsin Inhibitor in Chitosan-Whey Protein Nanoparticles on Hepatic Injury Induced High Glycemic Index Diet: A Preclinical Study. Int J Mol Sci 2021;22:9968. [PMID: 34576130 DOI: 10.3390/ijms22189968] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
12 Strainiene S, Peciulyte M, Strainys T, Stundiene I, Savlan I, Liakina V, Valantinas J. Management of Flood syndrome: What can we do better? World J Gastroenterol 2021; 27(32): 5297-5305 [PMID: 34539133 DOI: 10.3748/wjg.v27.i32.5297] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
13 Oh Y, Yoo SY, Choi GS, Kim G. Liver transplantation of a patient with extreme thrombocytopenia - A case report. Anesth Pain Med (Seoul) 2021;16:279-83. [PMID: 34233411 DOI: 10.17085/apm.21006] [Reference Citation Analysis]
14 Ding JN, Zhao WF. Mechanism, diagnosis, and treatment of portal vein thrombosis in cirrhosis. Shijie Huaren Xiaohua Zazhi 2021; 29(12): 670-676 [DOI: 10.11569/wcjd.v29.i12.670] [Reference Citation Analysis]
15 Lombard FW, Popescu WM, Oprea AD, Kertai MD. Perioperative thrombocytopenia. Curr Opin Anaesthesiol 2021;34:335-44. [PMID: 33935182 DOI: 10.1097/ACO.0000000000000999] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Franco JB, Andrade NS, Bueno MVRDS, Peres MPSM, Medina JB, Tenório JDR, Rech BO, Ortega KL. Assessment of laboratory tests and intraoperative bleeding in patients with liver cirrhosis undergoing tooth extractions. Oral Surg Oral Med Oral Pathol Oral Radiol 2021:S2212-4403(21)00459-4. [PMID: 34275775 DOI: 10.1016/j.oooo.2021.05.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Scharf RE. Thrombocytopenia and Hemostatic Changes in Acute and Chronic Liver Disease: Pathophysiology, Clinical and Laboratory Features, and Management. J Clin Med 2021;10:1530. [PMID: 33917431 DOI: 10.3390/jcm10071530] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
18 Mussbacher M, Brunnthaler L, Panhuber A, Starlinger P, Assinger A. Till Death Do Us Part-The Multifaceted Role of Platelets in Liver Diseases. Int J Mol Sci 2021;22:3113. [PMID: 33803718 DOI: 10.3390/ijms22063113] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
19 Tanaka H, Imai H, Higashi T, Murase K, Matsuhashi N, Yoshida K. Pancreaticoduodenectomy combined with splenectomy for a patient with pancreatic cancer and pancytopenia due to liver cirrhosis: Case report. Int J Surg Case Rep 2021;81:105715. [PMID: 33689973 DOI: 10.1016/j.ijscr.2021.105715] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Brown RS Jr, Imawari M, Izumi N, Osaki Y, Bentley R, Ochiai T, Kano T, Peck-Radosavljevic M. Assessing the periprocedural magnitude of platelet count change in response to lusutrombopag. JHEP Rep 2021;3:100228. [PMID: 33644726 DOI: 10.1016/j.jhepr.2021.100228] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
21 Bosch J. Small diameter shunts should lead to safe expansion of the use of TIPS. J Hepatol 2021;74:230-4. [PMID: 32987029 DOI: 10.1016/j.jhep.2020.09.018] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
22 Nomoto H, Morimoto N, Miura K, Watanabe S, Takaoka Y, Maeda H, Sasaki T, Koyashiki Y, Kurata H, Numao N, Isoda N, Yamamoto H. Lusutrombopag is effective and safe in patients with chronic liver disease and severe thrombocytopenia: a multicenter retrospective study. BMC Gastroenterol 2020;20:427. [PMID: 33317473 DOI: 10.1186/s12876-020-01573-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
23 de Oliveira Rech B, Rocha Tenório J, Bertoldi Franco J, Medina JB, Gallottini M, Pérez-Sayáns M, Ortega KL. Risk of bleeding during oral surgery in patients with liver cirrhosis: A systematic review. J Am Dent Assoc 2021;152:46-54.e2. [PMID: 33250169 DOI: 10.1016/j.adaj.2020.09.018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
24 Zanetto A, Barbiero G, Battistel M, Sciarrone SS, Shalaby S, Pellone M, Battistella S, Gambato M, Germani G, Russo FP, Burra P, Senzolo M. Management of portal hypertension severe complications. Minerva Gastroenterol (Torino) 2021;67:26-37. [PMID: 33140623 DOI: 10.23736/S2724-5985.20.02784-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
25 Numata K, Tanaka K, Katsube T, Ochiai T, Fukuhara T, Kano T, Osaki Y, Izumi N, Imawari M. Is platelet monitoring during 7-day lusutrombopag treatment necessary in chronic liver disease patients with thrombocytopenia undergoing planned invasive procedures? A phase IIIb open-label study. Hepatol Res 2020;50:1141-50. [PMID: 32609920 DOI: 10.1111/hepr.13544] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
26 Dieterich DT, Bernstein D, Flamm S, Pockros PJ, Reau N. Review article: a treatment algorithm for patients with chronic liver disease and severe thrombocytopenia undergoing elective medical procedures in the United States. Aliment Pharmacol Ther 2020;52:1311-22. [PMID: 32813292 DOI: 10.1111/apt.16044] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
27 Schulick AC, Moore HB, Walker CB, Yaffe H, Pomposelli JJ, Azam F, Wachs M, Bak T, Kennealey P, Conzen K, Adams M, Pshak T, Choudhury R, Chapman MP, Pomfret EA, Nydam TL. A clinical coagulopathy score concurrent with viscoelastic testing defines opportunities to improve hemostatic resuscitation and enhance blood product utilization during liver transplantation. Am J Surg 2020;220:1379-86. [PMID: 32907709 DOI: 10.1016/j.amjsurg.2020.07.034] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]